Pasteur Institute
Paris, Paris, France
Purpose
To provide project management support for the ongoing clinical and technical development of a 4-valent synthetic O-antigen-surrogate Shigella conjugate vaccine developed to prevent morbidity and mortality in infants and children
Division
Global Health
Date
November 2024
Region Served
GLOBAL
Committed amount
$345,000
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
31
Grantee location
Paris, Paris, France
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.